Cells homozygous for disrupted target loci

{
  "publication_number": "US5589369A",
  "country": "US",
  "kind": "A",
  "title": "Cells homozygous for disrupted target loci",
  "abstract": "Homozygotic cells are obtained by employing homologous recombination with a construct comprising a marker gene. The marker gene allows for selection without amplification and by employing elevated levels of the antibiotic to which the marker gene imparts resistance, gene conversion can occur, where in a diploid host, both copies of the target locus will be the same. In this manner, knock-outs of genes can be readily achieved without requiring two steps of homologous recombination.",
  "claims": [
    "1. A method for making diploid mammalian cells homozygous for disrupted target loci, said method comprising: a. introducing into diploid mammalian cells a construct, said construct comprising a selectable marker gene flanked by regions of sequence homology to said loci, wherein said marker gene is a non-amplifiable gene which confers on said cells a preferential ability to grow in a selective medium; b. growing the cells obtained in step (a) in said selective medium at a first level of selective agent and analyzing viable cells to provide a population of cells which have undergone homologous recombination at one or both of the target loci; c. subjecting the population of cells obtained in step (b) to a level of selective agent greater that said first level, whereby cells which have undergone homologous recombination at both loci are selected; and d. isolating said cells obtained in step (c).",
    "2. A method according to claim 1, wherein said marker gene is an antibiotic resistance gene.",
    "3. A method according to claim 2, wherein said antibiotic resistance gene is a neomycin resistance gene.",
    "4. A method according to claim 1, wherein said marker gene is flanked by at least 50 bp of sequence homologous with said target loci.",
    "5. A method according to claim 4, wherein said homologous sequence is mutated from said target loci sequence.",
    "6. A method according to claim 1, wherein said host cells are embryonic stem cells.",
    "7. A method for making mammalian embryonic stem cells which are homozygous for disrupted target loci, said method comprising: a. introducing into mammalian embryonic stem cells a construct, said construct comprising a selectable marker gene flanked by regions of sequence homologous to said loci, wherein said marker gene is a non-amplifiable gene which confers on said cells a preferential ability to grow in a selective medium; b. growing the cells obtained in step (a) in said selective medium at a first level of selective agent and analyzing viable cells to provide a population of cells which have undergone homologous recombination at one or both of the target loci; c. subjecting the population of cells obtained in step (b) to a level of selective agent greater that said first level, whereby cells which have undergone homologous recombination at both loci are selected; and d. isolating said cells obtained in step (c).",
    "8. A method according to claim 7, wherein said antibiotic resistance gene is a neomycin resistance gene.",
    "9. A method according to claim 7, wherein said marker gene is flanked by at least 50 bp of sequence homologous with said target loci.",
    "10. A method according to claim 9, wherein said homologous sequence is mutated from said target loci sequence.",
    "11. A method according to claim 7, wherein said target locus is a surface membrane protein loci."
  ],
  "cpc": [
    "C12N 15/8509",
    "A01K 2217/075",
    "A01K 2227/105",
    "A01K 2267/03",
    "A01K 67/0276",
    "A61K 48/00",
    "C12N 15/65",
    "C12N 15/85",
    "C12N 15/907"
  ],
  "assignees": [
    "CELL GENESYS INC",
    "HARVARD COLLEGE"
  ],
  "filing_date": "1994-05-31",
  "publication_date": "1996-12-31",
  "grant_date": "1996-12-31",
  "priority_date": "1992-02-11",
  "application_number": "US-25204894-A",
  "family_id": "25265825"
}